Author: Francisca Verdugo-Paiva; Ariel Izcovich; Martin Ragusa; Gabriel Rada
Title: Lopinavir/ritonavir f?or the treatment of COVID-19: A living systematic review protocol Document date: 2020_4_17
ID: mhi6w4mr_58
Snippet: We will perform subgroup analysis according to the definition of severe COVID-19 infection (i.e respiratory failure vs respiratory distress syndrome vs ICU requirement). In case we identify significant differences between subgroups (test for interaction <0.05) we will report the results of individual subgroups separately. We will perform sensitivity analysis excluding high risk of bias studies, and if non-randomised studies are used, excluding st.....
Document: We will perform subgroup analysis according to the definition of severe COVID-19 infection (i.e respiratory failure vs respiratory distress syndrome vs ICU requirement). In case we identify significant differences between subgroups (test for interaction <0.05) we will report the results of individual subgroups separately. We will perform sensitivity analysis excluding high risk of bias studies, and if non-randomised studies are used, excluding studies that did not report adjusted estimates. In cases where the primary analysis effect estimates and the sensitivity analysis effect estimates significantly differ we will either present the low risk of bias -adjusted sensitivity analysis estimates -or present the primary analysis estimates but downgrading the certainty of the evidence because of risk of bias.
Search related documents:
Co phrase search for related documents- evidence certainty and ICU requirement: 1
- evidence certainty and ICU requirement vs distress syndrome: 1
- evidence certainty and interaction test: 1
- evidence certainty and low risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- evidence certainty and non randomised study: 1, 2, 3
- evidence certainty and primary analysis effect: 1, 2, 3
- evidence certainty and primary analysis effect estimate: 1
- evidence certainty and primary analysis estimate: 1
- evidence certainty and respiratory failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- evidence certainty and respiratory ICU requirement vs distress syndrome: 1
- evidence certainty and sensitivity analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- evidence certainty downgrade and high risk: 1
- evidence certainty downgrade and low risk: 1
- evidence certainty downgrade and respiratory failure: 1
- evidence certainty downgrade and sensitivity analysis: 1
- evidence certainty downgrade and significant difference: 1
- significant difference and subgroup analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- significantly differ and subgroup analysis: 1, 2, 3, 4, 5
- significantly differ and subgroup analysis perform: 1
Co phrase search for related documents, hyperlinks ordered by date